Marc Adrian Rogmann,Edoardo Zancanaro,Hendrik Treede et al.
Marc Adrian Rogmann et al.
For decades tricuspid valve regurgitation (TR) was considered clinically insignificant and often left untreated. Only with the emergence of catheter-based treatment, particularly tricuspid transcatheter edge-to-edge repair (T-TEER), the con...
The multidisciplinary Heart Team in mitral valve transcatheter edge-to-edge repair [0.03%]
经导管二尖瓣边对边修复术中的多学科心脏团队
Christoph S Mueller,Christian Hagl,Jörg Hausleiter et al.
Christoph S Mueller et al.
Treatment options for mitral regurgitation (MR) have markedly evolved over the past few decades, with mitral valve transcatheter edge-to-edge repair (M-TEER) expanding the clinical armamentarium of guideline-directed medical therapy and sur...
[The heart team in coronary artery disease-perspectives from centers without institutional cardiac surgery] [0.03%]
冠心病的“心脏团队”——来自没有结构性心血管外科机构中心的观点
M Winhard,M Krane,S Hakmi et al.
M Winhard et al.
The management of coronary artery disease (CAD) has become more demanding due to evolving therapeutic options and more complex patient profiles. In this context, the heart team has become established: a structured, interdisciplinary decisio...
[Diagnosis and treatment of heart failure with preserved ejection fraction] [0.03%]
射血分数保留的心力衰竭的诊断和治疗
Samira Soltani,Johann Bauersachs
Samira Soltani
The treatment of heart failure with preserved ejection fraction (HFpEF) involves symptomatic management of congestion with diuretics (class I recommendation) and treatment with sodium-glucose linked transporter 2 (SGLT2) inhibitors for impr...
Prognosticating short-term outcomes in patients with STEMI-ACS and intra-procedural slow-flow/no-reflow phenomenon [0.03%]
STEMI-ACS患者术中慢血流/无复流现象的短期预后评估
Rajesh Kumar,Abdul Hakeem Shaikh,Ayaz Mir et al.
Rajesh Kumar et al.
Background: In this study, we compared the incidence of short-term outcomes between two groups of patients based on the occurrence of intra-procedural slow-flow/no-reflow phenomenon (SF/NR) and identified predictors of sh...
Rolf Dörr,Diethelm Tschöpe,Nikolaus Marx
Rolf Dörr
Editorial
Herz. 2025 Aug;50(4):227-228. DOI:10.1007/s00059-025-05320-2 2025
Samira Soltani,Johann Bauersachs
Samira Soltani
The diagnosis of heart failure with reduced ejection fraction (HFrEF) is based on clinical symptoms, such as peripheral edema or dyspnea and a left ventricular ejection fraction (LVEF) of 40% or less. Treatment is based particularly on the ...
[Palliative care and change in treatment goals for heart failure in the outpatient sector : A survey among office-based physicians in Germany on the current state of healthcare provision] [0.03%]
德国门诊心脏衰竭患者姑息性治疗和治疗目标变化的调查:当前医疗现状的医师问卷调查
Moritz Blum,Mark Weber-Krüger,Hashim Abdul-Khaliq et al.
Moritz Blum et al.
Background: Palliative care is a crucial part of the holistic management of advanced heart failure; however, it remains unclear how palliative care is currently provided in the outpatient sector in Germany. ...
Big data and cardiovascular risk-insights into obesity, diabetes, and coronary heart disease [0.03%]
大数据与心血管风险——肥胖、糖尿病和冠心病的新认识
Marcus Dörr
Marcus Dörr
Background: Cardiovascular diseases (CVD) remain a major global health burden. Obesity and type 2 diabetes mellitus (T2DM) are key modifiable risk factors for coronary heart disease (CHD). The emergence of big data has re...
Cardiovascular risk reduction in patients with diabetes mellitus and/or chronic kidney disease-an update [0.03%]
糖尿病和/或慢性肾脏病患者的心血管风险降低——更新版
Katharina Marx-Schütt
Katharina Marx-Schütt
People with diabetes mellitus have a significantly increased risk of developing cardiovascular disease as well as chronic kidney disease. The coexistence of these comorbidities has a significant impact on prognosis. In August 2023, the Euro...